Treasurer Of The State Of North Carolina Neurocrine Biosciences Inc Transaction History

Treasurer Of The State Of North Carolina

  • $25 Billion
  • Q3 2024

A detailed history of Treasurer Of The State Of North Carolina transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 68,568 shares of NBIX stock, worth $10.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
68,568
Previous 70,116 2.21%
Holding current value
$10.5 Million
Previous $9.65 Million 18.16%
% of portfolio
0.03%
Previous 0.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$114.58 - $153.15 $177,369 - $237,076
-1,548 Reduced 2.21%
68,568 $7.9 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $143,160 - $156,649
1,094 Added 1.59%
70,116 $9.65 Million
Q1 2024

May 09, 2024
BUY
$130.4 - $143.74 $26,471 - $29,179
203 Added 0.29%
69,022 $9.52 Million
Q4 2023

Feb 12, 2024
BUY
$106.07 - $132.76 $61,096 - $76,469
576 Added 0.84%
68,819 $9.07 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $79,446 - $98,949
-845 Reduced 1.22%
68,243 $7.68 Million
Q2 2023

Aug 14, 2023
BUY
$89.53 - $104.87 $35,812 - $41,948
400 Added 0.58%
69,088 $6.52 Million
Q1 2023

May 04, 2023
BUY
$94.11 - $123.02 $22,586 - $29,524
240 Added 0.35%
68,688 $6.95 Million
Q4 2022

Feb 09, 2023
BUY
$106.72 - $127.06 $866,566 - $1.03 Million
8,120 Added 13.46%
68,448 $8.18 Million
Q3 2022

Nov 08, 2022
BUY
$92.03 - $107.81 $1.86 Million - $2.18 Million
20,240 Added 50.49%
60,328 $6.41 Million
Q2 2022

Aug 02, 2022
BUY
$75.79 - $100.07 $426,621 - $563,294
5,629 Added 16.34%
40,088 $3.91 Million
Q1 2022

May 10, 2022
BUY
$72.45 - $94.81 $39,485 - $51,671
545 Added 1.61%
34,459 $3.23 Million
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $1.07 Million - $1.43 Million
-13,496 Reduced 28.47%
33,914 $2.89 Million
Q3 2021

Nov 03, 2021
BUY
$86.18 - $99.03 $64,548 - $74,173
749 Added 1.61%
47,410 $4.55 Million
Q2 2021

Aug 13, 2021
SELL
$89.43 - $102.27 $164,551 - $188,176
-1,840 Reduced 3.79%
46,661 $4.54 Million
Q1 2021

May 03, 2021
SELL
$87.57 - $119.4 $267,964 - $365,364
-3,060 Reduced 5.93%
48,501 $4.72 Million
Q4 2020

Feb 02, 2021
BUY
$86.91 - $108.33 $30,418 - $37,915
350 Added 0.68%
51,561 $4.94 Million
Q3 2020

Nov 04, 2020
SELL
$96.16 - $135.15 $619,270 - $870,366
-6,440 Reduced 11.17%
51,211 $4.92 Million
Q2 2020

Aug 07, 2020
SELL
$85.09 - $130.36 $497,351 - $761,954
-5,845 Reduced 9.21%
57,651 $7.03 Million
Q1 2020

May 13, 2020
BUY
$75.11 - $113.76 $1.22 Million - $1.84 Million
16,185 Added 34.21%
63,496 $5.5 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $217,868 - $297,610
-2,510 Reduced 5.04%
47,311 $5.09 Million
Q3 2019

Nov 07, 2019
SELL
$83.82 - $101.5 $972,311 - $1.18 Million
-11,600 Reduced 18.89%
49,821 $4.49 Million
Q2 2019

Aug 23, 2019
BUY
$72.24 - $91.27 $249,227 - $314,881
3,450 Added 5.95%
61,421 $5.19 Million
Q1 2019

Aug 07, 2019
BUY
$69.31 - $91.53 $411,632 - $543,596
5,939 Added 11.41%
57,971 $5.11 Million
Q4 2018

Aug 07, 2019
BUY
$68.32 - $124.36 $202,090 - $367,856
2,958 Added 6.03%
52,032 $3.72 Million
Q3 2018

Aug 07, 2019
BUY
$98.88 - $125.85 $2.87 Million - $3.65 Million
28,991 Added 144.36%
49,074 $6.04 Million
Q2 2018

Aug 07, 2019
BUY
$75.3 - $105.99 $892,154 - $1.26 Million
11,848 Added 143.87%
20,083 $1.97 Million
Q1 2018

Jul 24, 2019
BUY
$75.88 - $92.43 $624,871 - $761,161
8,235 New
8,235 $683,000

Others Institutions Holding NBIX

# of Institutions
638
Shares Held
93.7M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email